Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Docetaxel/Cisplatin/5-Fluorouracil Followed by Surgery

Keijiro Sugimura(Osaka International Cancer Institute), Masahiko Yano(Nagoya Sangyo University), Kei Asukai(Osaka International Cancer Institute), Masayuki Ohue(Hyogo Medical University), Hiroshi Wada, Hiroshi Miyata(Osaka University), Yoshitomo Yanagimoto(Osaka International Cancer Institute), Kazuyoshi Yamamoto(Osaka International Cancer Institute), Yusuke Takahashi(Jikei University School of Medicine), Junichi Nishimura, Naoki Shinno(Osaka International Cancer Institute), Hidenori Takahashi(Osaka International Cancer Institute), Shinnichiro Hasegawa(Osaka International Cancer Institute), Masayoshi Yasui(Osaka International Cancer Institute), Takeshi Omori(Osaka International Cancer Institute), Daisaku Yamada(Osaka International Cancer Institute), Hajime Ushigome(Osaka International Cancer Institute), Masaaki Motoori(Osaka International Cancer Institute)
Oncology
January 1, 2019
Cited by 26


Related Papers